US Stock MarketDetailed Quotes

NGNE Neurogene

Watchlist
  • 42.260
  • +0.840+2.03%
Close Jul 19 16:00 ET
  • 43.690
  • +1.430+3.38%
Post 17:36 ET
548.55MMarket Cap-14922P/E (TTM)

Neurogene Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.72%-21.65M
2.65%-51.42M
-9.33M
-13.56M
-13.84%-52.82M
-46.4M
Net income from continuing operations
-37.98%-16.92M
34.20%-36.32M
---11.86M
---12.26M
-9.25%-55.19M
---50.52M
Depreciation and amortization
0.86%825K
3.03%3.3M
--1.15M
--818K
237.91%3.2M
--947K
Other non cash items
215.63%505K
-2,680.92%-15.69M
----
--160K
-10.46%608K
--679K
Change In working capital
-163.32%-6.75M
-49.28%-4.02M
--1.16M
---2.56M
-268.97%-2.7M
--1.6M
-Change in prepaid assets
-81.67%-1.42M
-54.47%326K
--146K
---780K
136.14%716K
---1.98M
-Change in payables and accrued expense
-193.02%-4.74M
-3.78%-2.91M
--1.18M
---1.62M
-165.97%-2.8M
--4.25M
-Change in other current assets
--21K
---764K
----
--0
--0
----
-Change in other current liabilities
-271.34%-609K
-11.15%-678K
---167K
---164K
8.96%-610K
---670K
Cash from discontinued investing activities
Operating cash flow
-59.72%-21.65M
2.65%-51.42M
---9.33M
---13.56M
-13.84%-52.82M
---46.4M
Investing cash flow
Cash flow from continuing investing activities
103,324.14%29.94M
1,249.64%25.64M
-82K
-29K
87.86%-2.23M
-18.37M
Net PPE purchase and sale
-124.14%-65K
85.61%-321K
---82K
---29K
87.86%-2.23M
---18.37M
Net investment purchase and sale
--30M
--5M
----
--0
--0
----
Net other investing changes
----
--20.96M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
103,324.14%29.94M
1,249.64%25.64M
---82K
---29K
87.86%-2.23M
---18.37M
Financing cash flow
Cash flow from continuing financing activities
-6,197.20%-6.52M
39.01%92.48M
-86K
107K
30.29%66.53M
51.06M
Net issuance payments of debt
-120.00%-11K
-2,800.00%-29K
---6K
---5K
---1K
--0
Net common stock issuance
----
--92.34M
----
----
--0
----
Net preferred stock issuance
----
--0
----
----
30.89%66.46M
--50.78M
Proceeds from stock option exercised by employees
461.61%629K
130.14%168K
--20K
--112K
-74.56%73K
--287K
Net other financing activities
---7.14M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-6,197.20%-6.52M
39.01%92.48M
---86K
--107K
30.29%66.53M
--51.06M
Net cash flow
Beginning cash position
81.32%148.72M
16.27%82.02M
--68.54M
--82.02M
-16.27%70.54M
--84.25M
Current changes in cash
113.07%1.76M
481.14%66.7M
---9.5M
---13.48M
183.74%11.48M
---13.71M
End cash Position
119.54%150.48M
81.32%148.72M
--59.05M
--68.54M
16.27%82.02M
--70.54M
Free cash flow
-59.86%-21.72M
6.01%-51.74M
---9.41M
---13.58M
15.00%-55.05M
---64.77M
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.72%-21.65M2.65%-51.42M-9.33M-13.56M-13.84%-52.82M-46.4M
Net income from continuing operations -37.98%-16.92M34.20%-36.32M---11.86M---12.26M-9.25%-55.19M---50.52M
Depreciation and amortization 0.86%825K3.03%3.3M--1.15M--818K237.91%3.2M--947K
Other non cash items 215.63%505K-2,680.92%-15.69M------160K-10.46%608K--679K
Change In working capital -163.32%-6.75M-49.28%-4.02M--1.16M---2.56M-268.97%-2.7M--1.6M
-Change in prepaid assets -81.67%-1.42M-54.47%326K--146K---780K136.14%716K---1.98M
-Change in payables and accrued expense -193.02%-4.74M-3.78%-2.91M--1.18M---1.62M-165.97%-2.8M--4.25M
-Change in other current assets --21K---764K------0--0----
-Change in other current liabilities -271.34%-609K-11.15%-678K---167K---164K8.96%-610K---670K
Cash from discontinued investing activities
Operating cash flow -59.72%-21.65M2.65%-51.42M---9.33M---13.56M-13.84%-52.82M---46.4M
Investing cash flow
Cash flow from continuing investing activities 103,324.14%29.94M1,249.64%25.64M-82K-29K87.86%-2.23M-18.37M
Net PPE purchase and sale -124.14%-65K85.61%-321K---82K---29K87.86%-2.23M---18.37M
Net investment purchase and sale --30M--5M------0--0----
Net other investing changes ------20.96M----------------
Cash from discontinued investing activities
Investing cash flow 103,324.14%29.94M1,249.64%25.64M---82K---29K87.86%-2.23M---18.37M
Financing cash flow
Cash flow from continuing financing activities -6,197.20%-6.52M39.01%92.48M-86K107K30.29%66.53M51.06M
Net issuance payments of debt -120.00%-11K-2,800.00%-29K---6K---5K---1K--0
Net common stock issuance ------92.34M----------0----
Net preferred stock issuance ------0--------30.89%66.46M--50.78M
Proceeds from stock option exercised by employees 461.61%629K130.14%168K--20K--112K-74.56%73K--287K
Net other financing activities ---7.14M--------------------
Cash from discontinued financing activities
Financing cash flow -6,197.20%-6.52M39.01%92.48M---86K--107K30.29%66.53M--51.06M
Net cash flow
Beginning cash position 81.32%148.72M16.27%82.02M--68.54M--82.02M-16.27%70.54M--84.25M
Current changes in cash 113.07%1.76M481.14%66.7M---9.5M---13.48M183.74%11.48M---13.71M
End cash Position 119.54%150.48M81.32%148.72M--59.05M--68.54M16.27%82.02M--70.54M
Free cash flow -59.86%-21.72M6.01%-51.74M---9.41M---13.58M15.00%-55.05M---64.77M
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg